Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin or aspirin-dipyridamole for preventing serious vascular events in high risk patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Thienopyridine Derivatives (ticlopidine, Clopidogrel) Versus Aspirin or Aspirin-dipyridamole for Preventing Serious Vascular Events in High Risk Patients." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454852/all/__________Thienopyridine_derivatives__ticlopidine__clopidogrel__versus_aspirin_or_aspirin_dipyridamole_for_preventing_serious_vascular_events_in_high_risk_patients______.
Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin or aspirin-dipyridamole for preventing serious vascular events in high risk patients. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/454852/all/__________Thienopyridine_derivatives__ticlopidine__clopidogrel__versus_aspirin_or_aspirin_dipyridamole_for_preventing_serious_vascular_events_in_high_risk_patients______. Accessed November 14, 2024.
Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin or aspirin-dipyridamole for preventing serious vascular events in high risk patients. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/454852/all/__________Thienopyridine_derivatives__ticlopidine__clopidogrel__versus_aspirin_or_aspirin_dipyridamole_for_preventing_serious_vascular_events_in_high_risk_patients______
Thienopyridine Derivatives (ticlopidine, Clopidogrel) Versus Aspirin or Aspirin-dipyridamole for Preventing Serious Vascular Events in High Risk Patients [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454852/all/__________Thienopyridine_derivatives__ticlopidine__clopidogrel__versus_aspirin_or_aspirin_dipyridamole_for_preventing_serious_vascular_events_in_high_risk_patients______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin or aspirin-dipyridamole for preventing serious vascular events in high risk patients
ID - 454852
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454852/all/__________Thienopyridine_derivatives__ticlopidine__clopidogrel__versus_aspirin_or_aspirin_dipyridamole_for_preventing_serious_vascular_events_in_high_risk_patients______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -